As of close of business last night, Vera Therapeutics Inc’s stock clocked out at $13.16, down -2.73% from its previous closing price of $13.53. On the day, 494416 shares were traded. VERA stock price reached its highest trading level at $13.81 during the session, while it also had its lowest trading level at $12.92.
To gain a deeper understanding of VERA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.64 and its Current Ratio is at 6.64. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.22.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on November 10, 2023, Upgraded its rating to Buy and sets its target price to $26 from $18 previously.
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 21 when Fordyce Marshall sold 5,210 shares for $16.66 per share. The transaction valued at 86,779 led to the insider holds 243,361 shares of the business.
Curley Joanne sold 1,490 shares of VERA for $24,817 on Aug 21. The Chief Development Officer now owns 26,962 shares after completing the transaction at $16.66 per share. On Aug 21, another insider, Lin Celia, who serves as the Chief Medical Officer of the company, sold 1,490 shares for $16.65 each. As a result, the insider received 24,816 and left with 11,010 shares of the company.
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VERA now has a Market Capitalization of 584.74M and an Enterprise Value of 454.32M.
Stock Price History:
Over the past 52 weeks, VERA has reached a high of $21.02, while it has fallen to a 52-week low of $5.20. The 50-Day Moving Average of the stock is 12.53, while the 200-Day Moving Average is calculated to be 11.76.
It appears that VERA traded 584.07K shares on average per day over the past three months and 575.91k shares per day over the past ten days. A total of 44.43M shares are outstanding, with a floating share count of 28.21M. Insiders hold about 36.51% of the company’s shares, while institutions hold 68.49% stake in the company. Shares short for VERA as of Oct 30, 2023 were 4.96M with a Short Ratio of 4.96M, compared to 4.89M on Sep 28, 2023. Therefore, it implies a Short% of Shares Outstanding of 11.19% and a Short% of Float of 14.79%.
As of right now, 6 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.51 for the current quarter, with a high estimate of -$0.42 and a low estimate of -$0.57, while EPS last year was -$1.18. The consensus estimate for the next quarter is -$0.54, with high estimates of -$0.43 and low estimates of -$0.64.
Analysts are recommending an EPS of between -$2.06 and -$2.28 for the fiscal current year, implying an average EPS of -$2.19. EPS for the following year is -$2.24, with 5 analysts recommending between -$1.81 and -$2.79.